Literature DB >> 17698030

Coexistence of mitochondrial 12S rRNA C1494T and CO1/tRNA(Ser(UCN)) G7444A mutations in two Han Chinese pedigrees with aminoglycoside-induced and non-syndromic hearing loss.

Huijun Yuan1, Jing Chen1, Xin Liu1, Jing Cheng1, Xinjian Wang2, Li Yang2, Shuzhi Yang1, Juyang Cao1, Dongyang Kang1, Pu Dai1, Suoqiang Zhai1, Dongyi Han3, Wie-Yen Young4, Min-Xin Guan5.   

Abstract

Mutations in mitochondrial DNA are one of the important causes of hearing loss. We report here the clinical, genetic, and molecular characterization of two Han Chinese pedigrees with maternally transmitted aminoglycoside-induced and nonsyndromic bilateral hearing loss. Clinical evaluation revealed the wide range of severity, age-at-onset, and audiometric configuration of hearing impairment in matrilineal relatives in these families. The penetrances of hearing loss in these pedigrees were 20% and 18%, when aminoglycoside-induced deafness was included. When the effect of aminoglycosides was excluded, the penetrances of hearing loss in these seven pedigrees were 10% and 15%. Sequence analysis of the complete mitochondrial genomes in these pedigrees showed the presence of the deafness-associated 12S rRNA C1494T and CO1/tRNA(Ser(UCN)) G7444A mutations. Their distinct sets of mtDNA polymorphism belonged to Eastern Asian haplogroup C4a1, while other previously identified six Chinese mitochondrial genomes harboring the C1494T mutation belong to haplogroups D5a2, D, R, and F1, respectively. This suggested that the C1494T or G7444A mutation occurred sporadically and multiplied through evolution of the mitochondrial DNA (mtDNA). The absence of functionally significant mutations in tRNA and rRNAs or secondary LHON mutations in their mtDNA suggest that these mtDNA haplogroup-specific variants may not play an important role in the phenotypic expression of the 12S rRNA C1494T and CO1/tRNA(Ser(UCN)) G7444A mutations in those Chinese families. However, aminoglycosides and other nuclear modifier genes play a modifying role in the phenotypic manifestation of the C1494T mutation in these Chinese families.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698030     DOI: 10.1016/j.bbrc.2007.07.161

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Very high penetrance and occurrence of Leber's hereditary optic neuropathy in a large Han Chinese pedigree carrying the ND4 G11778A mutation.

Authors:  Xiangtian Zhou; Hongxing Zhang; Fuxin Zhao; Yanchun Ji; Yi Tong; Juanjuan Zhang; Yu Zhang; Li Yang; Yaping Qian; Fan Lu; Jia Qu; Min-Xin Guan
Journal:  Mol Genet Metab       Date:  2010-04-29       Impact factor: 4.797

Review 2.  PharmGKB summary: very important pharmacogene information for MT-RNR1.

Authors:  Julia M Barbarino; Tracy L McGregor; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2016-12       Impact factor: 2.089

3.  The ND4 G11696A mutation may influence the phenotypic manifestation of the deafness-associated 12S rRNA A1555G mutation in a four-generation Chinese family.

Authors:  Zhisu Liao; Jianyue Zhao; Yi Zhu; Li Yang; Aifen Yang; Dongmei Sun; Zhongnong Zhao; Xinjian Wang; Zhihua Tao; Xiaowen Tang; Jindan Wang; Minqiang Guan; Jiafu Chen; Zhiyuan Li; Jianxin Lu; Min-Xin Guan
Journal:  Biochem Biophys Res Commun       Date:  2007-08-15       Impact factor: 3.575

4.  Mitochondrial DNA mutation screening in an ethnically diverse nonsyndromic deafness cohort.

Authors:  Richard J Vivero; Xiaomei Ouyang; Denise Yan; Lilin Du; Wendy Liu; Simon I Angeli; Xue Zhong Liu
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-01

5.  An MRPS12 mutation modifies aminoglycoside sensitivity caused by 12S rRNA mutations.

Authors:  Sonia Emperador; David Pacheu-Grau; M Pilar Bayona-Bafaluy; Nuria Garrido-Pérez; Antonio Martín-Navarro; Manuel J López-Pérez; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Front Genet       Date:  2015-01-14       Impact factor: 4.599

6.  Screening for deafness-associated mitochondrial 12S rRNA mutations by using a multiplex allele-specific PCR method.

Authors:  Yu Ding; Jianyong Lang; Junkun Zhang; Jianfeng Xu; Xiaojiang Lin; Xiangyu Lou; Hui Zheng; Lei Huai
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

7.  Mitochondrial DNA variant m.15218A > G in Finnish epilepsy patients who have maternal relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus.

Authors:  Heidi K Soini; Jukka S Moilanen; Tiina Vilmi-Kerälä; Saara Finnilä; Kari Majamaa
Journal:  BMC Med Genet       Date:  2013-07-19       Impact factor: 2.103

8.  Simultaneous multi‑gene mutation screening using SNPscan in patients from ethnic minorities with nonsyndromic hearing‑impairment in Northwest China.

Authors:  Shi-Hong Duan; Jian-Li Ma; Xiao-Long Yang; Yu-Fen Guo
Journal:  Mol Med Rep       Date:  2017-09-07       Impact factor: 2.952

Review 9.  Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity.

Authors:  Zewen Gao; Ye Chen; Min-Xin Guan
Journal:  J Otol       Date:  2017-02-11

10.  Screening for mitochondrial 12S rRNA C1494T mutation in 655 patients with non-syndromic hearing loss: An observational study.

Authors:  Zhen Gao; Ya-Sheng Yuan
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.